GMCN-6250

N/A

Report date: 2025/11/19 17:47:59

Base Information

Drug NameGMCN-6250
Drug Alias NameGMCN6250
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhongji Zhiyao (Nanjing) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhongji Zhiyao (Nanjing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A